AI management approved for type 2 diabetes

Israel’s DreaMed (see here previously) has now received US FDA approval for use with Type 2 diabetes sufferers as well as Type 1. It will relieve the strain on endocrinologist who each have on average some 46,000 patients.

https://www.timesofisrael.com/spotlight/israeli-startup-offers-hope-in-global-diabetes-crisis/

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published.